Abdun-Nabi Daniel

Average Profitability
48.31%
Insider Buys Quantity
3
Insider Buys Sum
$77,894.44
Insider Sells Quantity
48
Insider Sells Sum
$30.17M

Insider Activity of Abdun-Nabi Daniel

The largest purchase of all time was on 2019-06-25 and amounted to 33334 shares of Aptevo Therapeutics Inc. for $30,001.

The largest sale of all time was on 2018-09-04 and amounted to 120000 shares of Emergent BioSolutions Inc. for $4.44M.

Biography of Abdun-Nabi Daniel

No biography is available at this moment.

2019-06-25PurchaseAptevo Therapeutics Inc.
APVO
Board of Directors
33,334
0.0753%
$0.90$30,001-33.16%
2019-03-04SaleEmergent BioSolutions Inc.
EBS
CEO
29,130
0.0573%
$58.11$1.69M-8.95%
2018-09-17SaleEmergent BioSolutions Inc.
EBS
CEO
2,638
0.0053%
$65.00$171,470-16.15%
2018-09-14SaleEmergent BioSolutions Inc.
EBS
CEO
28,220
0.0116%
$13.38$377,584-14.25%
2018-09-05SaleEmergent BioSolutions Inc.
EBS
CEO
61,552
0.1223%
$59.49$3.66M-4.77%
2018-09-04SaleEmergent BioSolutions Inc.
EBS
CEO
120,000
0.1451%
$36.96$4.44M-6.67%
2018-06-05SaleEmergent BioSolutions Inc.
EBS
Chief Executive Officer
31,570
0.0624%
$52.11$1.65M+11.01%
2018-01-02SaleEmergent BioSolutions Inc.
EBS
President & CEO
43,812
0.0574%
$31.18$1.37M+12.97%
2017-12-13SaleEmergent BioSolutions Inc.
EBS
President & CEO
40,000
0.0592%
$30.21$1.21M+16.38%
2017-11-03SaleEmergent BioSolutions Inc.
EBS
President & CEO
43,016
0.084%
$37.22$1.6M+21.64%
2017-09-27SaleEmergent BioSolutions Inc.
EBS
President & CEO
30,000
0.0564%
$30.97$929,220+27.31%
2017-08-31SaleEmergent BioSolutions Inc.
EBS
President & CEO
30,000
0.0577%
$29.62$888,600+34.48%
2017-01-10SaleEmergent BioSolutions Inc.
EBS
President and CEO
56,480
0.1395%
$31.28$1.77M+10.53%
2016-06-01SaleEmergent BioSolutions Inc.
EBS
President & CEO
17,398
0.0435%
$43.74$760,989-31.08%
2016-05-20SaleEmergent BioSolutions Inc.
EBS
President & CEO
17,402
0.0432%
$42.00$730,884-28.69%
2016-04-18SaleEmergent BioSolutions Inc.
EBS
President & CEO
17,404
0.0434%
$40.17$699,119-24.57%
2015-12-24SaleEmergent BioSolutions Inc.
EBS
President & CEO
45,710
0.1164%
$39.17$1.79M-15.04%
2015-12-23SaleEmergent BioSolutions Inc.
EBS
President & CEO
80,708
0.1532%
$28.95$2.34M-14.23%
2013-11-30PurchaseEmergent BioSolutions Inc.
EBS
CEO
1,498
0.0035%
$19.08$28,582
2013-05-31PurchaseEmergent BioSolutions Inc.
EBS
CEO
1,600
0.0038%
$12.07$19,312+48.31%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.